Anaplastic Lymphoma Kinase Rearrangement and Response to Crizotinib in Pancreatic Ductal Adenocarcinoma

被引:9
|
作者
Tuli, Richard [1 ]
Lo, Simon [1 ]
Koo, Jaimie [1 ]
Pishvaian, Michael [2 ]
Bender, R. Joseph [2 ]
Petricoin, Emanuel [2 ]
Brody, Jonathan [2 ]
Nissen, Nicholas [1 ]
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Perthera, Mclean, VA USA
关键词
D O I
10.1200/PO.17.00016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [31] Hepatoid Carcinoma of the Lung with Anaplastic Lymphoma Kinase Gene Rearrangement
    Khozin, Sean
    Roth, Mark J.
    Rajan, Arun
    Smith, Karen
    Thomas, Anish
    Berman, Arlene
    Giaccone, Giuseppe
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : E29 - E31
  • [32] Identification of ROS1 Rearrangement in Pancreatic Ductal Adenocarcinoma
    Voss, S. M.
    Yang, Z.
    Zander, D. S.
    Bruggeman, R.
    Hollenbeak, C. S.
    Karamchandani, D. M.
    LABORATORY INVESTIGATION, 2014, 94 : 456A - 456A
  • [33] Identification of ROS1 Rearrangement in Pancreatic Ductal Adenocarcinoma
    Voss, S. M.
    Yang, Z.
    Zander, D. S.
    Bruggeman, R.
    Hollenbeak, C. S.
    Karamchandani, D. M.
    MODERN PATHOLOGY, 2014, 27 : 456A - 456A
  • [34] Large Cell Neuroendocrine Carcinoma Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement with Response to Alectinib
    Hayashi, Nobuyoshi
    Fujita, Akihisa
    Saikai, Toyohiro
    Takabatake, Hirotugu
    Sotoshiro, Mie
    Sekine, Kyuutarou
    Kawana, Akihiko
    INTERNAL MEDICINE, 2018, 57 (05) : 713 - 716
  • [35] Anaplastic lymphoma kinase-positive lung adenocarcinoma patient with development of sick sinus syndrome while on targeted treatment with crizotinib
    Jiang, Hao
    Li, Mei-Mei
    Jin, Shu-Xian
    JOURNAL OF THORACIC DISEASE, 2015, 7 (03) : E19 - E22
  • [36] Combination of crizotinib and chemotherapy in patients with relapsed or refractory anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL)
    Chen, Mei-ting
    Fu, Xiao-hong
    Huang, He
    Wang, Zhao
    Fang, Xiao-jie
    Yao, Yu-Yi
    Ren, Quan-Guang
    Chen, Ze-geng
    Lin, Tong-yu
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 571 - 580
  • [37] Copy number gain in recurrent anaplastic lymphoma kinase (ALK) rearrangement-lung adenocarcinoma in the pleural effusion
    Abe, Hideyuki
    Kawahara, Akihiko
    Azuma, Koichi
    Murakami, Yuichi
    Takase, Yorihiko
    Naito, Yoshiki
    Akiba, Jun
    DIAGNOSTIC CYTOPATHOLOGY, 2018, 46 (09) : 744 - 747
  • [38] Neoadjuvant alectinib in locally advanced lung adenocarcinoma with anaplastic lymphoma kinase rearrangement: case series and literature review
    Wang, Zhaofeng
    Wu, Ranpu
    Li, Chuling
    Cheng, Kai
    Di, Yicheng
    Lv, Tangfeng
    Liu, Hongbing
    Song, Yong
    ANTI-CANCER DRUGS, 2023, 34 (10) : 1069 - 1075
  • [39] Clinicopathological Features and Therapeutic Responses of Chinese Patients with Advanced Lung Adenocarcinoma Harboring an Anaplastic Lymphoma Kinase Rearrangement
    Zeng, De
    Lin, Danxia
    Chen, Chen
    Wu, Xiao
    Wang, Miaojun
    Chen, Jiongyu
    Lin, Hui
    Qiu, Xihui
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (1-2) : 27 - 33
  • [40] IκB Kinase ε Expression in Pancreatic Ductal Adenocarcinoma
    Cheng, Anna
    Guo, Jianping
    Henderson-Jackson, Evita
    Kim, Donghwa
    Malafa, Mokenge
    Coppola, Domenico
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 136 (01) : 60 - 66